TY - JOUR
T1 - Center-Effect of Incident Hemodialysis Vascular Access Use
T2 - Analysis of a Bi-national Registry
AU - Ng, Samantha
AU - Pascoe, Elaine M.
AU - Johnson, David W.
AU - Hawley, Carmel M.
AU - Polkinghorne, Kevan R.
AU - McDonald, Stephen
AU - Clayton, Philip A.
AU - Rabindranath, Kannaiyan S.
AU - Roberts, Matthew A.
AU - Irish, Ashley B.
AU - Viecelli, Andrea K.
N1 - Funding Information:
The ANZDATA Registry is funded by the Australian Organ Transplantation Authority, the New Zealand Ministry of Health, and Kidney Health Australia. Astellas Pharmaceuticals provided nondirected contributions, and the National Health and Medical Research Council and Kidney Health Australia provided research support.
Publisher Copyright:
Copyright © 2021 by the American Society of Nephrology.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Background Commencing hemodialysis (HD) with an arteriovenous access is associated with superior patient outcomes compared with a catheter, but the majority of patients in Australia and New Zealand initiate HD with a central venous catheter. This study examined patient and center factors associated with arteriovenous fistula/graft access use at HD commencement. Methods We included all adult patients starting chronic HD in Australia and New Zealand between 2004 and 2015. Access type at HD initiation was analyzed using logistic regression. Patient-level factors included sex, age, race, body mass index (BMI), smoking status, primary kidney disease, late nephrologist referral, comorbidities, and prior RRT. Center-level factors included size; transplant capability; home HD proportion; incident peritoneal dialysis (average number of patients commencing RRT with peritoneal dialysis per year); mean weekly HD hours; average blood flow; and achievement of phosphate, hemoglobin, and weekly Kt/V targets. The study included 27,123 patients from 61 centers. Results Arteriovenous access use at HD commencement varied four-fold from 15% to 62% (median 39%) across centers. Incident arteriovenous access use was more likely in patients aged 51-72 years, males, and patients with a BMI of >25 kg/m 2 and polycystic kidney disease; but use was less likely in patients with a BMI of <18.5 kg/m 2, late nephrologist referral, diabetes mellitus, cardiovascular disease, chronic lung disease, and prior RRT. Starting HD with an arteriovenous access was less likely in centers with the highest proportion of home HD, and no center factor was associated with higher arteriovenous access use. Adjustment for center-level characteristics resulted in a 25% reduction in observed intercenter variability of arteriovenous access use at HD initiation compared with the model adjusted for only patient-level characteristics. Conclusions This study identified several patient and center factors associated with incident HD access use, yet these factors did not fully explain the substantial variability in arteriovenous access use across centers.
AB - Background Commencing hemodialysis (HD) with an arteriovenous access is associated with superior patient outcomes compared with a catheter, but the majority of patients in Australia and New Zealand initiate HD with a central venous catheter. This study examined patient and center factors associated with arteriovenous fistula/graft access use at HD commencement. Methods We included all adult patients starting chronic HD in Australia and New Zealand between 2004 and 2015. Access type at HD initiation was analyzed using logistic regression. Patient-level factors included sex, age, race, body mass index (BMI), smoking status, primary kidney disease, late nephrologist referral, comorbidities, and prior RRT. Center-level factors included size; transplant capability; home HD proportion; incident peritoneal dialysis (average number of patients commencing RRT with peritoneal dialysis per year); mean weekly HD hours; average blood flow; and achievement of phosphate, hemoglobin, and weekly Kt/V targets. The study included 27,123 patients from 61 centers. Results Arteriovenous access use at HD commencement varied four-fold from 15% to 62% (median 39%) across centers. Incident arteriovenous access use was more likely in patients aged 51-72 years, males, and patients with a BMI of >25 kg/m 2 and polycystic kidney disease; but use was less likely in patients with a BMI of <18.5 kg/m 2, late nephrologist referral, diabetes mellitus, cardiovascular disease, chronic lung disease, and prior RRT. Starting HD with an arteriovenous access was less likely in centers with the highest proportion of home HD, and no center factor was associated with higher arteriovenous access use. Adjustment for center-level characteristics resulted in a 25% reduction in observed intercenter variability of arteriovenous access use at HD initiation compared with the model adjusted for only patient-level characteristics. Conclusions This study identified several patient and center factors associated with incident HD access use, yet these factors did not fully explain the substantial variability in arteriovenous access use across centers.
KW - arteriovenous access
KW - arteriovenous fistula
KW - center characteristics
KW - center effect
KW - center size
KW - center variation
KW - central venous catheter
KW - dialysis
KW - hemodialysis
KW - vascular access
UR - http://www.scopus.com/inward/record.url?scp=85130504594&partnerID=8YFLogxK
U2 - 10.34067/KID.0005742020
DO - 10.34067/KID.0005742020
M3 - Article
C2 - 35373038
AN - SCOPUS:85130504594
SN - 2641-7650
VL - 2
SP - 674
EP - 683
JO - Kidney360
JF - Kidney360
IS - 4
ER -